Interim results for the six months ended June 30, 2025 Exhibit 99.1 September 12, 2025 Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company") Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today announces its unaudited interim results for the six months ended June 30, 2025 which will also be made available on the Company's website at www.biodexapharma.com. OPERATIONA ...